Upgrade to SI Premium - Free Trial

InMed Pharmaceuticals Inc. (INM)

1.85 +0.19 (11.45%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/10/25 *Est.)

Latest Headlines

Form 425 InMed Pharmaceuticals Filed by: InMed Pharmaceuticals Inc. July 22, 2026 4:32 PM - SEC Filing Form 425 InMed Pharmaceuticals Filed by: InMed Pharmaceuticals Inc. July 22, 2026 4:30 PM - SEC Filing Form 8-K InMed Pharmaceuticals For: Jul 22 July 22, 2026 4:28 PM - SEC Filing Mentari Therapeutics raises $200M in private placement tied to INM merger July 22, 2026 7:00 AM - StreetInsider Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline July 22, 2026 7:00 AM - PR NewsWire Form 425 InMed Pharmaceuticals Filed by: InMed Pharmaceuticals Inc. July 20, 2026 4:27 PM - SEC Filing Form 4 InMed Pharmaceuticals For: Jul 15 Filed by: Schneeberger Daniel July 17, 2026 7:29 PM - SEC Filing Form 4 InMed Pharmaceuticals For: Jul 14 Filed by: Vivo Opportunity Cayman Fund, L.P. July 16, 2026 9:58 PM - SEC Filing Form 425 InMed Pharmaceuticals Filed by: InMed Pharmaceuticals Inc. July 10, 2026 4:04 PM - SEC Filing Form 8-K InMed Pharmaceuticals For: Jul 06 July 10, 2026 4:02 PM - SEC Filing InMed amends merger deal with Mentari, files S-4 with SEC July 7, 2026 4:23 AM - StreetInsider InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4 July 6, 2026 6:22 PM - StreetInsider Form 4 InMed Pharmaceuticals For: Jun 30 Filed by: Vivo Opportunity Fund Holdings, L.P. July 2, 2026 7:02 PM - SEC Filing Form S-4 InMed Pharmaceuticals July 2, 2026 4:03 PM - SEC Filing Imunon names new interim CFO as predecessor retires June 30, 2026 4:40 PM - StreetInsider Form SCHEDULE 13D InMed Pharmaceuticals Filed by: Vivo Opportunity Fund Holdings, L.P. June 10, 2026 9:32 PM - SEC Filing Form 4 InMed Pharmaceuticals For: May 20 Filed by: Vivo Opportunity Cayman Fund, L.P. June 10, 2026 9:15 PM - SEC Filing Form 3 InMed Pharmaceuticals For: May 19 Filed by: Vivo Opportunity Cayman Fund, L.P. June 10, 2026 9:15 PM - SEC Filing Form 8-K InMed Pharmaceuticals For: Jun 03 June 10, 2026 6:03 AM - SEC Filing Form SCHEDULE 13G InMed Pharmaceuticals Filed by: ADAR1 Capital Management, LLC June 5, 2026 4:44 PM - SEC Filing InMed Pharmaceuticals regains nasdaq listing compliance June 4, 2026 5:02 PM - StreetInsider InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements June 4, 2026 5:02 PM - StreetInsider Form SCHEDULE 13G InMed Pharmaceuticals Filed by: Squadron Capital Management LLC May 27, 2026 4:08 PM - SEC Filing Form 4 InMed Pharmaceuticals For: May 19 Filed by: Schneeberger Daniel May 21, 2026 5:08 PM - SEC Filing Form 3 InMed Pharmaceuticals For: May 19 Filed by: Schneeberger Daniel May 21, 2026 4:51 PM - SEC Filing /C O R R E C T I O N -- InMed Pharmaceuticals/ May 20, 2026 10:35 AM - PR NewsWire /C O R R E C T I O N -- InMed Pharmaceuticals/ May 19, 2026 2:22 PM - PR NewsWire Form 425 InMed Pharmaceuticals Filed by: InMed Pharmaceuticals Inc. May 19, 2026 10:34 AM - SEC Filing Form 8-K InMed Pharmaceuticals For: May 19 May 19, 2026 10:33 AM - SEC Filing InMed to merge with Mentari in $290 million migraine therapy deal May 19, 2026 8:06 AM - StreetInsider InMed Pharmaceuticals & Mentari Therapeutics Announce Merger to Advance Migraine Prevention Therapies May 19, 2026 8:00 AM - PR NewsWire InMed Pharmaceuticals reduces exercise price on preferred investment options May 19, 2026 6:08 AM - StreetInsider InMed Pharmaceuticals Amends Preferred Investment Options May 19, 2026 6:06 AM - StreetInsider Form 8-K InMed Pharmaceuticals For: May 18 May 19, 2026 6:05 AM - SEC Filing Form 8-K InMed Pharmaceuticals For: May 06 May 7, 2026 6:02 AM - SEC Filing InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update May 6, 2026 6:02 PM - StreetInsider Form 10-Q InMed Pharmaceuticals For: Mar 31 May 6, 2026 5:25 PM - SEC Filing InMed Pharmaceuticals Amends Preferred Investment Options April 27, 2026 5:32 PM - StreetInsider Form 8-K InMed Pharmaceuticals For: Apr 21 April 27, 2026 4:58 PM - SEC Filing Full Article List